Louis R. Bégin

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

Marc Tischkowitz, Jean‐Sébastien Brunet, Louis R. Bégin et al. · BMC Cancer · 2007 · 368 citations · Full text

Medicine, Oncology, Pathology +17

The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of <b> <i>BRCA1</i> </b>-Related Breast Cancer

William D. Foulkes, Jean‐Sébastien Brunet, Ingunn M. Stefansson et al. · Cancer Research · 2004 · 364 citations

Medicine, Genetics, Oncology +14

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Mark E. Robson, Pierre O. Chappuis, Jaya M. Satagopan et al. · Breast Cancer Research · 2003 · 317 citations · Full text

Medicine, Genetics, Oncology +13

Estrogen Receptor Status in <b> <i>BRCA1</i> </b>- and <b> <i>BRCA2</i> </b>-Related Breast Cancer

William D. Foulkes, Kelly Metcalfe, Ping Sun et al. · Clinical Cancer Research · 2004 · 293 citations

Medicine, Genetics, Oncology +12

Epstein‐barr virus related lymphoepithelioma‐like carcinoma of lung

Louis R. Bégin, Jan Eskandari, J. H. Joncas et al. · Journal of Surgical Oncology · 1987 · 241 citations

Medicine, Oncology, Pathology +17